Home Overview Press Room Blog Publications For Students about us
Search

Inheritable Genetic Modification : Displaying 190-199 of 532


FDA Weighs Unknowns of 3-Person Embryo Fertilization[Quotes CGS's Marcy Darnovsky]by Matthew PerroneAssociated PressFebruary 26th, 2014Genetic experts cautioned that it could take decades to confirm the safety of an experimental technique, meant to prevent children from inheriting debilitating diseases, that would create babies from the DNA of three people.
Why the FDA should not green-light 3-parent reproduction[Quotes CGS's Marcy Darnovsky]by Paul KnoepflerKnoepfler Lab Stem Cell BlogFebruary 26th, 2014The FDA meeting is a great form for this discussion, although it leaves off the ethical and societal issues. Ultimately I hope the FDA says “no” to the technology. Humanity just isn’t ready and the risks are too great.
The New Science Of Three-Parent Babies[With CGS's Marcy Darnovsky]by Tom AshbrookNPR On PointFebruary 26th, 2014Mixing DNA from three people to produce one healthy baby. We’ll look at the controversial world of mitochondrial manipulation therapies to avoid inherited disease.
Genetically Modified Babiesby Marcy DarnovskyThe New York TimesFebruary 23rd, 2014An advisory committee of the Food and Drug Administration is set to consider radical biological procedures that, if successful, would produce genetically modified human beings. This is a dangerous step.
FDA Asked to Approve Creation of Genetically Modified Childrenby Stuart A. NewmanHuffington PostFebruary 20th, 2014The creation of "three-parent babies" has been touted as a relatively trivial tweaking of the reproductive process to enable women with compromised eggs to become genetic mothers of unaffected children. These claims of high impact health benefits from a low-risk procedure cannot be squared with scientific reality.
FDA Should Preserve International Consensus against Human Germline Modifications[Press statement]February 19th, 2014The US Food and Drug Administration will hold a public meeting to discuss “oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease.”
Letter Signed by Hundreds Sent to the FDA: Preserve the global consensus against human germline modificationby Jessica CussinsBiopolitical TimesFebruary 19th, 2014A sign-on letter prepared by the Center for Genetics and Society and the International Center for Technology Assessment has been sent to the FDA in anticipation of next week's discussion of a form of human germline modification.
FDA to Study “Three-Parent Embryos”[Quotes CGS]by Michael CookBioEdgeFebruary 16th, 2014On February 25 and 26 the US Food and Drug Administration will discuss a technique that is a form of human germline modification.
Rewriting the Human Genomeby Susan YoungMIT Technology ReviewFebruary 12th, 2014CRISPR could make gene therapies more broadly applicable, but, according to George Church, some scientists will be tempted to use it to engineer embryos during in vitro fertilization.
Questions Relating to 'Mitochondrial Replacement'by Calum MacKellarBioNewsFebruary 10th, 2014The term 'mitochondrial replacement' misrepresents reality while making it difficult for the general public to make an informed decision about the procedures and the grave ethical difficulties they raise for both individuals and the whole of society.
Displaying 190-199 of 532  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760